701. Comparison of MIC Results for Gepotidacin by Agar Dilution and Broth Microdilution Methods

BACKGROUND: Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor in clinical development for the treatment of gonorrhea and uncomplicated UTI (acute cystitis). Gepotidacin selectively inhibits bacterial DNA gyrase and topoisomerase IV by a unique mechani...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Open Forum Infect Dis
Auteurs principaux: Arends, S J Ryan, Canino, Michele A, Roth, Brieanna M, Rhomberg, Paul R, Flamm, Robert K, Scangarella-Oman, Nicole
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6811067/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz360.769
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires